Markets:

Overview

News

Currencies

International

Treasuries

Applied Therapeutics, Inc. - Common Stock (NQ:APLT)

0.2183 -0.0517 (-19.15%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Applied Therapeutics, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference

November 05, 2024

From Applied Therapeutics

Via GlobeNewswire

Steelcase Reports Weak Sales, Joins American Healthcare REIT And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

September 19, 2024

Via Benzinga

Dow Jumps Over 100 Points; Fed Cuts Interest Rates By 0.5% ↗

September 18, 2024

Via Benzinga

Topics Economy Stocks

Crude Oil Moves Lower; PowerFleet Shares Spike Higher ↗

September 18, 2024

Via Benzinga

Why Applied Therapeutics Stock Is Skyrocketing Today ↗

September 18, 2024

Investors are cheering good news from the FDA.

Via The Motley Fool

Applied Therapeutics: Q4 Earnings Insights ↗

March 06, 2024

Via Benzinga

Russell 2000 Outpaces S&P 500 As Small Caps Anticipate Fed's Interest Rate Move ↗

September 18, 2024

Small-cap stocks are surging ahead of the expected interest rate cut by the Federal Reserve, outperforming their larger-cap counterparts. However, potential for gains may be hindered by sluggish...

Via Benzinga

Topics Economy Stocks

Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic Disorder Drug ↗

September 18, 2024

Applied Therapeutics stock rises as the FDA no longer requires an Advisory Committee meeting, keeping the Priority Review on track, with the PDUFA target date set for November 28.

Via Benzinga

Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday ↗

September 18, 2024

Via Benzinga

Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia

September 18, 2024

From Applied Therapeutics

Via GlobeNewswire

Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket ↗

September 12, 2024

Via Benzinga

Applied Therapeutics to Participate in Upcoming Investor Conferences

September 04, 2024

From Applied Therapeutics

Via GlobeNewswire

Applied Therapeutics Reports Second Quarter 2024 Financial Results

August 07, 2024

From Applied Therapeutics

Via GlobeNewswire

Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, Analyst Sees 140% Stock Upside ↗

July 31, 2024

William Blair has initiated coverage on Applied Therapeutics highlighting its focus on rare diseases such as galactosemia, SORD deficiency, and diabetic cardiomyopathy. With govorestat (AT-007) poised...

Via Benzinga

CrossFirst Bankshares Posts Q2 Earnings, Joins Owens & Minor, Reddit And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

July 16, 2024

Via Benzinga

Applied Therapeutics Added to Russell 3000® Index

July 01, 2024

From Applied Therapeutics

Via GlobeNewswire

Top 4 Health Care Stocks That May Keep You Up At Night This Month ↗

June 11, 2024

Via Benzinga

APLT Stock Earnings: Applied Therapeutics Meets EPS, Misses Revenue for Q1 2024 ↗

May 09, 2024

APLT stock results show that Applied Therapeutics met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Applied Therapeutics Reports First Quarter 2024 Financial Results

May 09, 2024

From Applied Therapeutics

Via GlobeNewswire

Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference

May 07, 2024

From Applied Therapeutics

Via GlobeNewswire

Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer

April 15, 2024

From Applied Therapeutics

Via GlobeNewswire

Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024

April 04, 2024

From Applied Therapeutics

Via GlobeNewswire

FDA Presses Delay Button For Applied Therapeutics' First Potential Marketed Drug For Rare Disease ↗

April 01, 2024

FDA extends the review period for Applied Therapeutics' NDA for govorestat, targeting Classic Galactosemia treatment. The new action date is set for November 28, 2024. Applied Therapeutics anticipates...

Via Benzinga

Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket ↗

April 01, 2024

Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 01, 2024

Via Benzinga

Oxford Industries Posts Weak Results, Joins Applied Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

April 01, 2024

U.S. stock futures were higher this morning, with the Dow futures gaining by over 100 points on Monday.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 29, 2024

Via Benzinga

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia

March 28, 2024

From Applied Therapeutics

Via GlobeNewswire

EQT, Genie Energy And Other Big Stocks Moving Lower On Monday ↗

March 11, 2024

U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.

Via Benzinga

Topics Stocks

Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results

March 06, 2024

From Applied Therapeutics

Via GlobeNewswire

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.